Found tirzepatide: November 2026 price and position
As of November 20, 2026, Found charges $339 per 28-day cycle for compounded tirzepatide month to month, all-in, according to its own page. Over a year at that price you would pay $4,407 (13 four-week cycles).
Released · Last reviewed · how we verify
Found tirzepatide prices, read November 20, 2026
| Measure | Amount | Basis |
|---|---|---|
| Month to month, all-in | $339 | per 28-day cycle |
| Lowest printed rate | $199 | 12-month term, per 28-day cycle |
| 3 cycles (84 days) at the month-to-month price | $1,017 | 3 four-week charges |
| 6 cycles (168 days) at the month-to-month price | $2,034 | 6 four-week charges |
| 13 cycles (364 days) at the month-to-month price | $4,407 | 13 four-week charges |
Where Found sits
Among the 12 compounded programs in this dataset that print a month-to-month tirzepatide price that applies at every dose or at the maintenance dose, the median is $234 and the range runs from $85.58 (Collective) to $399 (Remedy Meds). Price check: 10 of them cost less over a year at their month-to-month price, among them Collective ($85.58 a month), Mondae ($126 a month), NexLife ($129 a month), Eden ($129 a month). Programs whose page shows only a starting-dose or coupon price are left out of this comparison, because their maintenance-dose month cannot be confirmed.
Limitations and what to check before you enroll
Compounded tirzepatide is not FDA-approved and is not the same product as Zepbound; it is made for an individual patient by a state-licensed pharmacy. Ask Found for the all-in price at the maintenance dose, what is charged today and how often, and which pharmacy fills the prescription. A clinician decides whether any GLP-1 is right for you.
Frequently asked
How much does Found charge for tirzepatide?
As of November 20, 2026, Found charges $339 per 28-day cycle for compounded tirzepatide month to month, all-in, according to its own page. Over a year at that price you would pay $4,407 (13 four-week cycles).
Is Found’s tirzepatide FDA-approved?
No. Compounded tirzepatide from any telehealth program, Found included, is not FDA-approved and is not the same product as Zepbound or Mounjaro. It is made for an individual patient by a state-licensed compounding pharmacy. Brand Zepbound is the FDA-approved version.
Where do these Found figures come from?
From Found’s own page (first-party read, changed, November 20, 2026), converted to an all-in month-to-month figure (medication plus any required recurring fee, before tax). The source link and read date are listed below, and the same figures are in the open dataset.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- Federal Register 91 FR 23431: proposed 503B bulks-list decision for semaglutide, tirzepatide and liraglutide (May 1, 2026; no final notice found as of November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- Wegovy (semaglutide) prescribing information on DailyMed (read November 20, 2026)
- Found pricing page (read November 20, 2026)
- Found semaglutide page (read November 20, 2026)